Antiplatelet treatment is one of the most important interventions for reducing the risk of recurrent vascular events including stroke. Most long-term evidence relates to aspirin, although combination antiplatelet therapy may offer the prospect of greater efficacy, tempered by an increased risk of bleeding. [2016]
-
- 5.0 Introduction
- 5.1 A comprehensive and personalised approach
- 5.2 Identifying risk factors
- 5.3 Carotid artery stenosis
- 5.4 Blood pressure
- 5.5 Lipid modification
- 5.6 Antiplatelet treatment
- 5.7 Anticoagulation
- 5.8 Other risk factors
- 5.9 Paroxysmal atrial fibrillation
- 5.10 Patent foramen ovale
- 5.11 Other cardioembolism
- 5.12 Vertebral artery disease
- 5.13 Intracranial artery stenosis
- 5.14 Oral contraception and hormone replacement therapy
- 5.14.1 Oral contraception
- 5.14.2 Hormone replacement therapy
- 5.15 Obstructive sleep apnoea
- 5.16 Antiphospholipid syndrome
- 5.17 Insulin resistance
- 5.18 Fabry disease
- 5.19 Cerebral Amyloid Angiopathy
- 5.20 CADASIL
- 5.21 Cerebral microbleeds
- 5.22 Lifestyle measures
- 5.23 Physical activity
- 5.24 Smoking cessation
- 5.25 Nutrition (secondary prevention)
- 5.26 Life after stroke
- 5.27 Further rehabilitation
- 5.28 Social integration and participation